Delivery Order SPE2DB20D2104-SPE2DB24FS69Z
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is for the delivery of Dupixent 300 mg/2 ml pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $2,538.70, has an ultimate completion date of April 8, 2024. This award was not set aside for any specific business type. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a ceiling value of $32,788.78 and an ultimate completion date of April 26, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,242.91 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Dupixent 300 mg/2 ml pen injectors. The contract, valued at $6,035.96, is a firm-fixed-price delivery order with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $15,640.23, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,652.35 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 17, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA), a defense agency. The $10,103.45 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 29, 2024 and was awarded on April 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $9,737.94, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 8, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The $25,339.82 firm-fixed-price contract has an ultimate completion date of August 19, 2022. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml pens to the U.S. government. The award was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $8,236.04 and an ultimate completion date of October 19, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS69ZDelivery Order
This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen injectors to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $41,342.43, was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, on February 22, 2024, with a completion date of February 23, 2024. The contract has a firm fixed price and is a delivery order, not a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award demonstrates Amerisourcebergen's role as a key vendor for the DLA, delivering essential medical commodities to military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.3k | 2/22/24 |